Announcementan
Biolexis Therapeutics Announces Positive Results from Expanded Diet Induced Obesity (DIO) Model Study for BLX-7006
Biolexis Therapeutics Inc.
PR-12-24-NI-133Dec 10, 2024
Microbiome
Mice Avoid Gaining Weight When Certain Gut Bacteria Are Present
Emilie Branch
Pharma's Almanac
PAO-M08-19-NI-023Aug 16, 2019
Identifying New Targets for Weight Loss Drugs
Emilie Branch
Pharma's Almanac
PA2344Jul 22, 2019
Drug Development
More Good News for Novo Nordisk’s Semaglutide and Weight Loss
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M03-18-NI-024Mar 23, 2018